All News
![](https://pbs.twimg.com/media/GE8RZHGWYAA_pUW.jpg)
Neutrophil signature in proliferative lupus nephritis.
@andreafava
#RNL2024
@RheumNow https://t.co/tNFIhohSvP
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
![](https://pbs.twimg.com/media/GE8PC3MXMAAW-0P.png)
Cancer and Myositis #RNL2024 @RheumNow
@DrLisaCS on Cancer screening:
Risk stratify: dermatomyositis, NXP2, TIFy, <40yo, refractory, dysphagia, cutaneous necrosis at higher risk
Enhanced risk stratification for those at risks, versus "basic screening" for lower risks https://t.co/3yy9Fx1pk8
Eric Dein ericdeinmd ( View Tweet)
![](https://pbs.twimg.com/media/GEto-tyXIAAgVPI.jpg)
Dr Christopher-Stine @DrLisaCS Factors which should influence (some very strongly) your cancer screening approach in myositis @RheumNow #RNL2024 https://t.co/BoyJLrVDwo
Richard Conway RichardPAConway ( View Tweet)
![](https://pbs.twimg.com/media/GE8Oi15XQAAQQCa.jpg)
anti-Sp4 Ab may be protective against cancer in myositis pts who are TIF1-g positive - Dr. L Christopher-Stine #RNL2024 @rheumnow https://t.co/n7Ikn3llGH
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GEto609XQAELqXg.jpg)
Continue to love this myositis diagram. Seems to be getting ever more complicated though! @DrLisaCS @RheumNow #RNL2024 https://t.co/eXz6144y3y
Richard Conway RichardPAConway ( View Tweet)
![](https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k_normal.jpg)
Cancer and Myositis #RNL2024 @RheumNow
@DrLisaCS
Dermatomyositis risks - TIF1y is highest risk, followed by NXP2
Protective features: childhood onset, ILD, arthralgias
Cancer and myositis often present w/in 1 yr before or after
Cancer is major cause of death
Eric Dein ericdeinmd ( View Tweet)
![](https://pbs.twimg.com/media/GE8K47NXUAAVCWm.jpg)
Are we overprescribing because guidelines may be skewed to favor the pharmaceutical industry? Interesting questions posed by Dr. A Kavanaugh #RNL2024 @rheumnow https://t.co/wEwHaWNY5k
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GE8KDoKWcAAQQqJ.jpg)
Dr. A Kavanaugh discussed Ethics #RNL2024: publication bias where positive results are likely to be published compared to those with no effects -- this is a sham study with made up data submitted to 2 different ortho journals. @rheumnow https://t.co/j6gVgA67nC
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GE8KgjkXIAAR2-9.png)
Kavanaugh on Medical Ethics
#RNL2024 @RheumNow
Bias in research for ++ outcomes leads to fudging/biased interpretations of results
Fabricated study results submitted to orthopedic journals:
- 97% acceptance for positive result, 80% for no-difference result. Bias towards +outcome https://t.co/x7JJabSs4z
Eric Dein ericdeinmd ( View Tweet)
![](https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k_normal.jpg)
Kavanaugh on Medical Ethics
#RNL2024 @RheumNow
How do we informed consent?
- How to fully inform pts in complex research?
- Or paternalistic to not provide detailed info
- How deep to disc risk/ben?
- Easier to study in countries w/o good SoC
Prior hx: prisoners, Nazi, Tuskegee
Eric Dein ericdeinmd ( View Tweet)
![](https://pbs.twimg.com/profile_images/1351717401415573513/Za85Ytpr_normal.jpg)
@drcassysims recommends @NIH resource: https://t.co/ebtvc2zYbE to guide lactation- updated and run by pharmacists. #RNL2024 @rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3_normal.jpg)
MTX and cyclophosphamide are the two drugs @DrCassySims recommends holding during breast feeding in our vasculitis patients. #RNL2024 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
![](https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3_normal.jpg)
Do you get extra-cranial imaging in your GCA patients? #rheumtwitter #RNL2024 @RheumNow @anisha_dua @DrCassySims @philseo
Dr. Rachel Tate uptoTate ( View Tweet)
![](https://pbs.twimg.com/media/GE8C7cDWcAAUIVu.jpg)
Dr P Seo answers audience questions…he does not check ANCA levels regularly as results do not impact his actions but may induce anxiety #Vasculitis #RNL2024 @RheumNow https://t.co/GV62DF7s3y
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3_normal.jpg)
@DrCassySims checks APS ab on ALL pregnant (vasculitis) patients. "HCQ decreases neonatal lupus risk by half, meaning great reward for little risk." CS at #RNL2024 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
![](https://pbs.twimg.com/media/GE8BvcjW4AACmgE.png)
Dr. P Seo's summary slide on management of #vasculitis #RNL2024 @rheumnow https://t.co/cZLI6iz1sL
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GE8BhW0W0AAEfi3.png)
How Dr. P Seo manages #vasculitis patients with nonrespiratory manifestations #RNL2024 @rheumnow https://t.co/sjTXulDZ3a
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GE8BcPLXAAAXdYn.jpg)
#RNL2024 vasculitis mavens answering questions. @RheumNow https://t.co/Lm1N666SlS
Dr. Rachel Tate uptoTate ( View Tweet)
![](https://pbs.twimg.com/media/GE8BLmpXMAA7igm.jpg)
While #dupilumab can be used for #EGPA, be careful about using it in pts with high eosinophilia; don't taper steroids too rapidly if you use this drug. - Dr P Seo @rheumnow #RNL2024 https://t.co/YKQdtvCS0M
TheDaoIndex KDAO2011 ( View Tweet)
![](https://pbs.twimg.com/media/GE8AVAlWoAAXaOR.jpg)
Consider using IV Benralizumab (also an IL5 inhibitor) for #EGPA in pts where insurance won't approve SQ mepolizumab - Dr. P Seo #RNL2024 @rheumnow https://t.co/VFE76Uzb2S
TheDaoIndex KDAO2011 ( View Tweet)